Navigation Links
P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company
Date:1/31/2008

CINCINNATI, Jan. 31, 2008 /PRNewswire-FirstCall/ -- The Procter & Gamble Company (NYSE: PG) announced net sales growth of nine percent to $21.6 billion for the quarter. Sales were up behind strong volume growth from continued success on key product initiatives and double-digit organic growth in developing regions. Organic volume increased six percent and organic sales were up five percent for the quarter. Diluted earnings per share increased 17 percent to $0.98 per share, above the top end of the company's $0.95 to $0.97 per share guidance range. Earnings grew as topline growth and continued Gillette synergy benefits more than offset higher commodity costs.

"This quarter is another demonstration of P&G's capability to deliver strong results in a difficult competitive and commodity cost environment," said A.G. Lafley, Chairman of the Board and Chief Executive Officer. "Solid topline growth and a sharp focus on cost control are driving strong profit and cash generation. Looking ahead, we are confident that the strength of the company's brand portfolio, initiative pipeline and productivity program will enable P&G to continue delivering at or ahead of its targets."

Executive Summary

-- Net sales increased nine percent to $21.6 billion behind six percent

organic volume growth. Every geographic region posted year-on-year

organic volume growth, led by double-digit growth in developing

regions.

-- Net Earnings grew 14 percent to $3.3 billion primarily behind the

combination of sales growth and overhead cost savings, which more than

offset the impact of higher commodity costs. Earnings per share

increased 17 percent to $0.98 for the quarter.

-- Operatin
'/>"/>

SOURCE The Procter & Gamble Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Nutraceutical Reports Fiscal 2008 Q1 Results
2. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
3. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
4. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
5. Encision Reports Third Fiscal Quarter Results
6. Zimmer Reports Fourth Quarter and 2007 Financial Results
7. Amylin Pharmaceuticals Reports 2007 Financial Results
8. Cystic Fibrosis Foundation reports upward trend for key health outcomes
9. NBTY Reports First Quarter Results
10. Moog Reports 14% Increase in Earnings Per Share
11. Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...Results of St. Jude study could shape new treatmen...Jan. 8 Scientists at St...ted a more effective treatment for bacterial pneum...biotics clindamycin and azithromycin, which kill b... more effective than a standard first-line treatme...
(Date:1/8/2009)...ew says it lowered bad cholesterol more effectivel...hDay News) -- After nearly a year of review, U.S. ... the continued use of the controversial cholestero...ug Administration said there was no significant di...nts taking Vytorin and patients taking the drug Zo...
(Date:1/8/2009)...BETHESDA, Md., Jan. 8 H...ased to announce that throughout the fourth quarte...rthotics Center, Rocky Mountain Orthotic-Prostheti...vices, Inc., First Coast Orthotics & Prostheti...hese acquisitions add patient care centers to exis...
(Date:1/8/2009)... SAN FRANCISCO, Jan. 8 /PRNewswire-FirstCall/ -...ced that David Hung, M.D., president and chief,ex....P. Morgan Healthcare,Conference on Wednesday, Ja...,St. Francis Hotel in San Francisco. , Dr....ts clinical,development programs for Dimebon for ...
Breaking Medicine News(10 mins):Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2
...ording to the author of the study, James Raftery, ...d that NICE is being partial with its decisions//....cellence (NICE) was set up as an independent body ...etting the best from NHS resources. It examines th...
...und 26,000 candidates would appear in the entrance...tigious Jawaharlal Nehru Institute of Post Graduat... These candidates will sit for the two-and-a-half...usly in Pondicherry, New Delhi, Chennai, Hyderabad...
...Wheeling Jesuit University some researchers found ...ood for keeping brain alert, controls impulses// a...e lovers were found to have better cognitive abili...alue to the above study, an under graduate student...
...a yoga techniques, the Chinese Tai chi and various...y health care programme held here on May 28 by the....// Conducted by Dr Girish Patel, secretary of th... ist by profession, the programme will deal with ...
Other Medicine News:
(Date:1/7/2009)..., MEMPHIS, Tenn., Jan. 7 /PRNewswire-USNewswire...e that predict a high likelihood of relapse in chi...hough the researchers caution that further researc...called IKZF1 or IKAROS, lead to leukemia relap...or future diagnostic tests to assess the risk of t...
(Date:1/7/2009)..., BEIJING, Jan. 7 Tiantan Puhua...puhua.com ), the worldwide leader in using stem ce...nnounced today six new globally experienced additi...cantly expand the hospital,s treatment capabilitie...tients. The six senior doctors include the disting...
(Date:1/6/2009)..., COMMACK, N.Y., Jan. 6 In rece...omer, University of Memphis , scientists found th...Carn(R), is the first and only proven ingredient t...; thereby increasing blood nitrate/nitrate (NOx) i...sodilator and enables an increase in blood flow to...
(Date:1/6/2009)..., PARSIPPANY, N.J., Jan. 6 ...alty pharmaceutical company, announced today that ...e III SIMPLE trials to evaluate the,safety and ef...f EXPAREL(TM),(DepoBupivacaine) for prolonged pos...udies in hemorrhoidectomy and in total knee,arthr...
Breaking Medicine Technology:Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3NASA enhanced dust storm predictions to aid health community 5629 1NASA enhanced dust storm predictions to aid health community 5629 2NASA enhanced dust storm predictions to aid health community 5629 3Carmex Takes Moisture to the Next Level With New Carmex Moisture Plus 28TM 29 28007 1Notice of conference call and webcast 8677 1Notice of conference call and webcast 8677 2Cialis May Help Ease Pulmonary Hypertension 28000 1Cialis May Help Ease Pulmonary Hypertension 28000 2
...akthrough Will Aid in Developing Therapies to Prev...RYVILLE, Calif., May 10, 2007 /PRNewswire/ -- Kine...lopment company, announced,today the first method ...es in animals through the pathway known as reverse...n mechanism by which excess,cholesterol can be rem...
...POLIS, France, May 11, 2007 /PRNewswire-FirstCall/...pdate on the phase 2a,study for NCX 1000, which is... Pharma Inc. A preliminary analysis of 11 patient...tension confirmed,the safety profile of NCX 1000 b...pport the continuation of this clinical trial. As ...
Other Medicine Technology:KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 3NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 2NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 3
...able laparoscopic 12 mm linear cutting stapler for...ium staples., ,The stapler places two triple, sta... the knife divides the tissue in between. The inst...e surgical procedure: it can be reloaded up to 7 t...
...g unit for reloadable rotating (360°) linear s...tion and anastomosis with titanium staples., ,The...nium staples and simultaneously the knife divides ...for multiple use during a single surgical procedur...
ENDO GIA ROTICULATOR™ Single Use Loading Units with Titanium Staples for use with the ENDO GIA™ Universal and GIA™ Universal Instrument (030403) Single Use Instrument (030449).
... Thoracic Endoscopic Linear Cutter has application...urgical procedures for transection, resection, and...taple line buttressing materials such as bovine pe... for a total of eight firings. Different cartridge...
Medicine Products: